T1	Participants 71 130	patients with advanced human immunodeficiency virus disease
T2	Participants 439 585	absolute CD4 lymphocyte count of < 200/microL (or prior AIDS-defining opportunistic infection), and the presence of serum IgG to Toxoplasma gondii
